# Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy

> **NCT01057693** · PHASE3 · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 633 (actual)

## Conditions studied

- Diabetic Neuropathy, Painful

## Interventions

- **DRUG:** pregabalin (Lyrica)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01057693
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03-31
- **Primary completion:** 2012-01-30
- **Final completion:** 2012-01-30
- **Target enrollment:** 633 (ACTUAL)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01057693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01057693, "Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01057693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*